BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 126 Скачать Далее
BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data Targeted Oncology 3:21 4 years ago 24 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
Progress With BTK Inhibitors: A Journey Through the Mechanisms of Covalent and Noncovalent Options PeerView Oncology 22:36 2 years ago 2 135 Скачать Далее
Real-world outcomes of brexu-cel in patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:45 1 year ago 70 Скачать Далее
Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:03 11 months ago 151 Скачать Далее
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 471 Скачать Далее
CITADEL-204: safety and efficacy of parsaclisib in R/R MZL VJHemOnc – Video Journal of Hematology & HemOnc 1:47 3 years ago 80 Скачать Далее
Safety & efficacy of LV20.19 CAR-T therapy in Richter's transformation and R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:12 1 year ago 83 Скачать Далее
The safety and efficacy of acalabrutinib for the treatment of R/R MZL VJHemOnc – Video Journal of Hematology & HemOnc 3:27 2 years ago 178 Скачать Далее
Safety and efficacy of pirtobrutinib in patients with R/R B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 0:57 1 year ago 112 Скачать Далее
Safety and efficacy of NX-2127 in R/R CLL: a Phase I study VJHemOnc – Video Journal of Hematology & HemOnc 1:27 1 year ago 109 Скачать Далее
Successful use of zanubrutinib for R/R MCL in China VJHemOnc – Video Journal of Hematology & HemOnc 2:40 5 years ago 131 Скачать Далее
Safety and efficacy of the novel BTK inhibitor zanubrutinib in patients with CLL/SLL ecancer 3:00 4 years ago 333 Скачать Далее
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:01 1 year ago 200 Скачать Далее